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AbstrACt
Objective Cigarette smoke-induced oxidative stress 
plays an important role in the pathogenesis of chronic 
obstructive pulmonary disease (COPD). Dietary 
antioxidants are thought to prevent smoke-induced 
oxidative damage. The aim of this study was to investigate 
associations between lung function and the consumption 
of antioxidant vitamins in Korean adults.
Methods In total, 21 148 participants from the Korean 
National Health and Nutrition Examination Survey (2007–
2014) were divided into four groups based on smoking 
history and gender. Multivariate regression models were 
used to evaluate associations between lung function and 
intake of dietary antioxidants.
results Subjects in the highest intake quintile (Q5) of 
vitamin A, carotene and vitamin C intake had mean forced 
expiratory volume in 1 s (FEV
1) measurements that were 
30 mL, 32 mL and 36 mL higher than those of individuals 
in the lowest intake quintile (Q1), respectively (p for 
trend; p=0.008, p=0.010 and p<0.001, respectively). 
The risks of COPD for male smokers in Q1 increased 
7.60-fold (95% CI 5.92 to 9.76), 7.16-fold (95% CI 5.58 
to 9.19) and 7.79-fold (95% CI 6.12 to 9.92), for vitamin 
A, carotene and vitamin C, respectively, compared with 
those of female non-smokers in Q5. Among patients with 
COPD, men who smoked >20 pack-years had mean FEV
1 
measurements that were 192 mL, 149 mL and 177 mL 
higher than those of patients in Q1 (p for trend; p=0.018, 
p=0.024 and p=0.043, for vitamin A, carotene and vitamin 
C, respectively).
Conclusions These findings indicate that the influence of 
antioxidant vitamins on lung function depends on gender 
and smoking status in the Korean COPD population.
IntrOduCtIOn 
Chronic obstructive pulmonary disease 
(COPD) causes morbidity and mortality.1 
Smoking is a primary risk factor for COPD; 
however, other factors also contribute as 
only 10%–20% of smokers develop airflow 
limitations.2 
Dietary antioxidants protect against oxida-
tive stress caused by smoking,3 and multiple 
studies have revealed associations between 
the intake of antioxidant vitamins or fibres 
and respiratory diseases.4–8 However, evidence 
supporting the benefits of vitamin supple-
ment therapy is lacking.9 10
Because micronutrient status is affected 
by dietary intake and metabolic turnover, 
which are regulated by oxidative stress, the 
benefits of antioxidant vitamins may vary by 
gender and smoking status. Multiple studies 
have shown that different antioxidants 
exhibit different effects based on smoking 
status. Morabia et al reported an association 
between airway obstruction and vitamin A 
intake in smokers compared with former 
smokers, whereas Hu et al reported that caro-
tene was less strongly associated with FEV1 in 
smokers compared with former smokers and 
non-smokers.11 12
This study used Korean National Health and 
Nutritional Examination Survey  (KNHANES) 
data to investigate whether dietary antioxi-
dant vitamins were independently associated 
with pulmonary function and COPD in the 
Korean population. This study also evaluated 
whether the effects of antioxidant vitamins 
on pulmonary function differed based on 
gender or smoking status.
PAtIents And MethOds
study population
Participants were sampled from KNHANES 
(2007–2014) IV–VI, a nationwide survey 
strengths and limitations of this study
 ► This study revealed that the influence of antioxidant 
vitamins on lung function depends on gender and 
smoking status in Korean patients with chronic ob-
structive pulmonary disease .
 ► This is a cross-sectional study with a large sample 
size collected from a national health survey.
 ► Main limitations include a possible recall bias and no 
further verification of nutritional intake.
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designed to be representative of the population that is 
used to establish health policies. KNHANES contains a 
massive database with information about demographic 
characteristics, comorbidities, lung function, nutritional 
status and health (https:// knhanes. cdc. go. kr/ knhanes).
A two-stage stratified systemic sampling method was use 
to select 65 973 individuals to survey between February 
2007 and December 2014. Of the chosen individuals, 
34 278 participants over 40 years of age responded to 
questionnaires regarding diet and smoking history and 
underwent a medical examination. After excluding 
subjects who omitted lung function or nutrition data, we 
analysed data from 21 148 (8804 men and 12 344 women) 
in this study. This study was approved by the Institutional 
Review Board of the Korean Centres for Disease Control 
and Prevention. All participants provided informed 
written consent.
PrOtOCOl
KNHANES collects survey data through health question-
naire surveys, screening surveys and nutrition surveys. 
Health questionnaires were divided into household 
survey, health interview survey and health behaviour 
survey. The health interview survey examined the use 
of medical services, activity limitations, education and 
economic activities and physical activity by interview 
method. The health behaviour survey examined smoking 
status, drinking, mental health and safety consciousness 
by self-filling method. The screening consisted of physical 
measurement, blood pressure and pulse measurement, 
blood and urine test, oral examination, pulmonary func-
tion test, visual and refractive examination, colour vision 
test, hearing test and muscle strength test. Nutrition 
surveys consisted of dietary behaviours, dietary supple-
ments, nutritional knowledge and the contents of food 
intake (24-hour recall method) a day before the survey.
spirometry and airflow obstruction definitions
The pulmonary function test was performed using 
dry-rolling seal volume spirometers (Model 2130; Sensor 
Medics, Yorba Linda, California, USA) and standardised 
according to the American Thoracic Society/European 
Respiratory Society criteria.13 Qualified technicians and 
principal investigators assessed the spirometry data for 
acceptability and reproducibility. The predictive equa-
tions for the forced expiratory volume in 1 s (FEV1) and 
the forced vital capacity (FVC) were derived from survey 
data on non-smokers who had normal chest X-rays and 




Food intake data were obtained using the 24-hour recall 
method, in which participants were asked to report the 
foods and amounts thereof consumed during the previous 
24 hours. Total energy (kJ/d (kcal/d)) and total intake 
of antioxidant vitamins were calculated using the Korean 
Food Composition Table16 as the reference. Antioxidant 
vitamin consumption was adjusted for total energy intake.
Potential confounders
Data regarding demographic information, education 
level, household income, smoking status, smoking 
amount, alcohol intake, place of residence, body mass 
index (BMI) and comorbid diseases were obtained. 
Educational level was categorised as elementary school 
or lower, completion of middle school, completion of 
high school and college or higher. Household income 
was divided by quartile. Place of residence was divided to 
rural and urban.
Smokers were subjects who smoked more than 100 ciga-
rettes in their lifetime.17 Participants were categorised in 
terms of smoking status as follows: smoker, ex-smoker or 
never smoked. Those who answered in the negative to 
the question ‘Do you currently smoke?’ were defined as 
ex-smokers.
The smoking amount was determined in pack-years, 
which was calculated by multiplying the duration of 
smoking (years) by the number of packs of cigarettes 
smoked. Comorbid diseases included hypertension, 
stroke, cardiovascular disease, arthritis, tuberculosis, 
asthma, diabetes mellitus, thyroid disorders, renal failure, 
liver disease and malignancy.
statistical analysis
A total of 21 148 subjects participated in this study 
(figure 1). The relationship between antioxidant vitamin 
intake and lung function was analysed using multiple 
linear regression analyses. We analysed the energy-ad-
justed antioxidant vitamin intake by quintiles. The 
adjustment factors were age, sex, BMI, educational level, 
household income, total energy intake, place of resi-
dence, number of comorbid diseases, smoking history, 
alcohol intake and pack-years.4 11 18 Assessments of linear 
trends across increasing antioxidant vitamin quintiles 
were also performed.
We estimated the ORs of COPD using multivariate 
logistic regression analyses of quintiles after adjusting 
for confounding factors. Participants were divided into 
four groups based on gender and smoking status (male 
smokers, male non-smokers, female smokers, female 
non-smokers) to determine whether the relationship 
between COPD risk and antioxidant vitamin intake is 
related to gender and smoking status. For combined 
analyses between the effects of antioxidant vitamin 
intake, gender and smoking status on the risk of COPD, 
interaction tests were performed. Patients with COPD 
and male patients with COPD were analysed separately. 
We attempted to determine whether the association 
of antioxidant vitamins and lung function varies with 
gender and smoking status in patients with COPD. 
Multiple linear regression analyses were performed after 
categorising patients with COPD by smoking status and 
amount.
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Statistical analyses were performed using PASW Statis-
tics V.20 (SPSS) and SAS V.9.4 (SAS Institute) software. 
P<0.05 was considered statistically significant.
results
The baseline characteristics of the 21 148 participants 
are shown in table 1. All subjects were classified into four 
groups based on smoking history and gender. Of the 7986 
smokers, 7178 were male (mean age, 57.8±11.0 years) 
and 808 were female (mean age, 57.4±12.5 years). Of 
the 13 162 individuals who had never smoked, 1626 were 
male (mean age, 57.9±11.3 years) and 11 536 were female 
(mean age, 57.1±10.8 years). Among all subjects, 3005 
were diagnosed with COPD. The prevalence of COPD was 
highest in male smokers (26.4%) and lowest in female 
non-smokers (6.4%).
The four groups differed regarding age, BMI, educa-
tional level, household income and alcohol usage 
(p<0.001). Energy intake was significantly higher in men 
than women (men, 2256.5 kcal; women, 1648.3 kcal; 
p<0.001). The levels of vitamin A, carotene and vitamin 
C were highest in the male non-smoker group and lowest 
in the female smoker group. Korean male non-smokers 
are predisposed to COPD compared with female 
non-smokers (incidence rate of 15.7% vs 6.4%). Age and 
the percentage of alcohol intake were higher in Korean 
male non-smokers than female non-smokers.
Table 2 showed the association between lung func-
tion (FEV1, FVC) and dietary antioxidant vitamin levels. 
Participants in the highest quintile (Q5) of vitamin A 
intake had 30 mL higher FEV1 (p for trend across quin-
tiles=0.008) and 33 mL higher FVC (p for trend across 
quintiles=0.007) compared with participants in the lowest 
quintile (Q1). Participants in Q5 for carotene intake had 
32 mL higher FEV1 (p for trend across quintiles=0.010) 
and 36 mL higher FVC (p for trend across quintiles=0.005) 
measurements compared with participants in Q1. Partic-
ipants in Q5 of vitamin C intake had 36 mL higher FEV1 
Figure 1 The study population framework. COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV2, 
forced expiratory volume in 2  s; KNHANES, Korean National Health and Nutritional Examination Survey . 
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(p for trend across quintiles<0.001) and 35 mL higher 
FVC (p for trend across quintiles=0.014) measurements 
compared with participants in Q1. A statistically signifi-
cant dose–response relationship was observed (all, p for 
trend across quintiles<0.005), but participants in Q3 of 
vitamin A and carotene had comparable lung function to 
those in Q5.
The effects of gender, smoking and dietary antioxidant 
vitamins on the risk of COPD are summarised in table 3. 
The risk of COPD for male smokers in Q1 for vitamin 
A, carotene and vitamin C intake increased by 7.60-fold 
(95% CI 5.92 to 9.76), 7.16-fold (95% CI 5.58 to 9.19) 
and 7.79-fold (95% CI 6.12 to 9.92), respectively, which 
was greater than that observed for female non-smokers 
in Q5 for antioxidant vitamin intake. Interestingly, the 
risk of COPD for male non-smokers in Q5 for vitamin 
A, carotene and vitamin C intake increased by 3.26-fold 
(95% CI 2.24 to 4.75). 3.35-fold (95% CI 2.31 to 4.86) and 
3.28-fold (95% CI 2.27 to 4.73), respectively, compared 
with female non-smokers in Q5 for antioxidant vitamin 
intake. The risk of COPD for male non-smokers in Q1 
for vitamin A, carotene and vitamin C intake increased 
by 2.80-fold (95% CI 1.90 to 4.12). 3.25-fold (95% CI 2.21 
to 4.78) and 3.17-fold (95% CI 2.04 to 4.91), respectively, 
compared with female non-smokers in Q1 for antioxidant 
vitamin intake. These results suggest that men may have 
other causes of COPD as well as smoking, compared with 
women who took similar amounts of antioxidant vitamins.
The interaction exists between the antioxidant vitamin 
intake and gender/smoking status on the risk of COPD 








P values(n=21 148) (n=7178) (n=1.626) (n=808) (n=11 536)
Age* 57.4 (10.9) 57.8 (11.0) 57.9 (11.3) 57.4 (12.5) 57.1 (10.8) <0.001
  40–49 6048 (28.6) 1998 (27.8) 464 (28.5) 273 (33.8) 3313 (28.7) <0.001
  50–59 6131 (29.0) 1981 (27.6) 431 (26.5) 199 (24.6) 3520 (30.5)
  60–69 5387 (25.5) 1913 (26.7) 430 (26.4) 158 (19.6) 2866 (25.0)
  70– 3582 (16.9) 1286 (17.9) 301 (18.5) 178 (22.0) 1817 (15.8)
BMI* 24.2 (3.0) 24.2 (2.8) 24.3 (2.8) 23.8 (3.6) 24.2 (3.2) 0.007
Education <0.001
  Elementary 7229 (34.2) 1763 (24.6) 321 (19.7) 381 (47.2) 4764 (41.3)
  Middle school 3315 (15.7) 1216 (16.9) 267 (16.4) 112 (13.9) 1720 (14.9)
  High school 6427 (30.4) 2366 (33.0) 458 (28.2) 228 (28.2) 3375 (29.3)
  More than college 4169 (19.7) 1831 (25.5) 580 (35.7) 87 (10.8) 1671 (14.5)
Household income <0.001
  First quartile 4763 (22.5) 1440 (20.1) 289 (17.8) 315 (39.0) 2719 (23.6)
  Second quartile 5427 (25.7) 1874 (26.1) 391 (24.1) 223 (27.6) 2939 (25.5)
  Third quartile 5162 (24.4) 1869 (26.1) 414 (25.5) 145 (17.9) 2734 (23.7)
  Fourth quartile 5780 (27.3) 1988 (27.7) 530 (32.6) 125 (15.5) 3137 (27.2)
Comorbidity* 0.9 (1.1) 0.9 (1.0) 0.8 (0.9) 1.0 (1.2) 1.0 (1.1) <0.001
Pack-years* 4.7 (13.6) 13.3 (20.3) 0.2 (2.2) 3.3 (11.9) 0.0 (0.0) <0.001
Alcohol 17 554 (83.0) 6877 (95.8) 1399 (86.0) 714 (88.4) 8564 (74.2) <0.001
Energy intake (kcal/
day)*
1901.5 (797.8) 2266.5 (869.7) 2212.6 (855.9) 1538.2 (653.4) 1656.0 (630.0) <0.001
Vitamin A (μg RE/day)* 822.5 (1118.5) 881.9 (1067.5) 925.5 (1095.2) 600.3 (644.2) 786.6 (1173.9) <0.001
Carotene (μg/day)* 4337.3 (6206.0) 4596.2 (5557.8) 4803.8 (5506.6) 3143.5 (3682.6) 4194.1 (6780.6) <0.001
Vitamin C (mg/day)* 111.9 (107.6) 111.8 (97.9) 128.8 (107.1) 84.8 (96.9) 111.5 (113.5) <0.001
FEV1 (mL)* 2.60 (0.67) 3.02 (0.68) 3.09 (0.66) 2.23 (0.56) 2.30 (0.46) <0.001
FVC (mL)* 3.38 (0.84) 4.07 (0.72) 4.04 (0.73) 2.88 (0.62) 2.89 (0.51) <0.001
FEV1/FVC (%)* 77.3 (7.9) 73.9 (9.1) 76.6 (7.9) 77.2 (8.0) 79.5 (6.1) <0.001
COPD 3005 (14.2) 1893 (26.4) 256 (15.7) 119 (14.7) 737 (6.4) <0.001
*Numbers represent mean percentages (SD).
BMI, body mass index; COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; RE, 
retinol equivalent. 
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Table 2 Mean values of adjusted lung function measurements across quintiles of vitamin A, carotene and vitamin C intake
Q1 Q2 Q3 Q4 Q5
Difference between 
Q5 and Q1 (95% CI)
P values for 
trend
Vitamin A
  Mean intake (μg RE) 151.2 353.6 573.1 893.9 2140.8
  FEV1 (mL) 2379 2389 2410 2397 2409 30 (10 to 50) 0.008
  FVC (mL) 3119 3136 3158 3148 3152 33 (10 to 57) 0.007
  Predicted FEV1 (%) 91.37 91.44 91.91 91.45 91.94 0.57 (-0.08 to 1.22) 0.185
  Predicted FVC (%) 90.93 91.06 91.45 91.22 91.48 0.55 (0.00 to 1.10) 0.195
Carotene
  Mean intake (μg) 691.1 1747.4 2938.9 4736.1 11 574.1
  FEV1 (mL) 2347 2363 2376 2370 2379 32 (12 to 52) 0.010
  FVC (mL) 3088 3117 3127 3119 3124 36 (13.59) 0.005
  Predicted FEV1 (%) 91.55 92.03 92.26 91.85 92.31 0.76 (0.12 to 1.39) 0.096
  Predicted FVC (%) 91.02 91.68 91.78 91.41 91.82 0.80 (0.26 to 1.33) 0.015
Vitamin C
  Mean intake (mg) 24.2 53.6 84.2 128.8 268.9
  FEV1 (mL) 2411 2423 2436 2441 2453 36 (16.56) <0.001
  FVC (mL) 3117 3122 3132 3140 3154 35 (12.58) 0.014
  Predicted FEV1 (%) 91.3 91.5 91.9 91.99 92.21 0.91 (0.27 to 1.55) 0.050
  Predicted FVC (%) 91.29 91.33 91.58 91.77 92.0 0.71 (0.17 to 1.26) 0.118
Data were adjusted for age, sex, body mass index, energy intake, number of comorbid diseases, alcohol consumption, place of residence 
smoking history, pack-years (smoking amount), household income and education level. P values were determined using tests for linear trends 
across increasing quintiles (means) of antioxidant vitamin intake.
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; RE, retinol equivalent; Q1, lowest quintile; Q5, highest quintile.
Table 3 Association between vitamin A, carotene and vitamin C intake and COPD according to gender and smoking status
Intake COPD OR P 
interactionQ5 Q1 Q5 Q1 Q5 Q1
Vitamin A <0.001
Female non-smokers 2096 2564 105 242 Ref 1.16 (0.89, 1.49)
Female smokers 109 264 16 53 3.90 (2.12, 7.17) 2.42 (1.63, 3.58)
Male non-smokers 394 225 53 47 3.26 (2.24, 4.75) 3.15 (2.10, 4.72)
Male smokers 1630 1176 320 444 5.54 (4.28, 7.16)* 7.60 (5.92, 9.76)*
Carotene
Female non-smokers 2118 2529 108 226 Ref 1.10 (0.85, 1.42) <0.001
Female smokers 104 268 15 49 3.47 (1.86, 6.47) 2.16 (1.45, 3.23)
Male non-smokers 397 243 55 50 3.35 (2.31, 4.86) 3.24 (2.18, 4.82)
Male smokers 1610 1189 321 425 5.83 (4.51, 7.53)* 7.16 (5.58, 9.19)*
Vitamin C
Female non-smokers 2303 2466 112 465 Ref 1.00 (0.77, 1.30) <0.001
Female smokers 107 294 12 35 2.37 (1.20, 4.71) 2.27 (1.55, 3.34)
Male non-smokers 401 191 55 55 3.28 (2.27, 4.73) 3.24 (2.07, 5.06)
Male smokers 1419 1278 317 204 6.20 (4.82, 7.98)* 7.79 (6.12, 9.92)*
OR was determined following adjustment for age, body mass index, energy intake, number of comorbid diseases, alcohol consumption, place 
of residence, household income and education level.
*The risk for COPD was significantly different between Q1 and Q5.
COPD, chronic obstructive pulmonary disease; Q1, lowest quintile; Q5, highest quintile.
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(all p values<0.001). The effect of the antioxidant vitamin 
intake depends on the gender/smoking status. When 
assessing the risk of COPD following reduction of antiox-
idant intake from Q5 to Q1, only male smokers showed 
significant difference in risk of COPD, but other three 
groups did not. Figure 2 shows that the risk of COPD 
was influenced by dietary antioxidant vitamin levels 
in male smokers in detail. In male smokers, the risk of 
COPD in subjects in Q5 for antioxidant vitamins intake 
was significantly lower than that for subjects in Q1 
(vitamin A, OR=0.77, 95% CI 0.63 to 0.94, p=0.009; caro-
tene, OR=0.81, 95% CI 0.67 to 0.99, p=0.041; vitamin C, 
OR=0.74, 95% CI 0.61 to 0.91, p=0.004). The dose–depen-
dent effect of vitamin C was observed between COPD risk 
and dietary antioxidant vitamin levels, but it was not for 
vitamin A and carotene. Although not significant, Q3 
group of carotene had increased risk to develop COPD 
than Q1 group of carotene.
The prevalence of COPD did not increase significantly 
as the intake of dietary antioxidant vitamins increased 
in male non-smokers, female smokers or female 
non-smokers. No significant interaction between the 
effects of antioxidant vitamins on COPD and smoking 
status was observed. The correlation between the risk of 
COPD and antioxidant vitamin intake was stronger in 
male smokers who smoked less than 20 pack-years (not 
shown).
We investigated the association between dietary anti-
oxidant vitamin intake and lung function after limiting 
the analyses to individuals with COPD. The changes in 
FEV1 were not statistically significant based on the levels 
of dietary antioxidant vitamins in subjects with COPD. 
Similar to the previous results, only male smokers in 
subjects with COPD, exhibited a beneficial association 
between dietary antioxidant vitamin intake and FEV1 
(figure 3). Male smokers with COPD in Q5 for vitamin A 
intake had a 71 mL higher FEV1 (p for trend across quin-
tiles=0.019) compared with those in Q1. Male smokers 
with COPD in Q5 of carotene and vitamin C intake had 
71 mL higher FEV1 (p for trend across quintiles=0.037) 
and a 109 mL higher FEV1 (p for trend across quin-
tiles=0.026), respectively, compared with individuals in 
Q1.
Additional analyses were performed to determine 
if lung function was reduced by smoking amount or 
smoking status in male smoker patients with COPD. 
Male patients with COPD who had smoked ≥20 pack-
years exhibited a beneficial association between dietary 
antioxidant vitamin intake and FEV1 (figure 4). Male 
patients with COPD in Q5 of vitamin A intake who had 
smoked ≥20 pack-years had a 192 mL higher FEV1 (p for 
trend across quintiles=0.018) compared with individuals 
in Q1. Patients with COPD in Q5 of carotene intake who 
had smoked ≥20 pack-years had a 149 mL higher FEV1 (p 
for trend across quintiles=0.024) compared with patients 
in Q1. Patients with COPD in Q5 of vitamin C intake who 
had smoked >20 pack-years had a 177 mL higher FEV1 (p 
for trend across quintiles=0.043) compared with patients 
in Q1.
dIsCussIOn
This study examined the association between the intake 
of antioxidant vitamins and lung functions in the Korean 
Figure 2 OR for the association between antioxidant vitamin intake and COPD among (A) male and (B) female smokers and 
non-smokers. OR were adjusted for age, body mass index, energy intake, number of comorbid diseases, alcohol consumption, 
place of residence, household income and education level.
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population. Previous studies showed that antioxidant vita-
mins, including vitamin C, were protective of the human 
lung,5 12 whereas high levels of vitamin A and carotene 
were also associated with increased lung functions in 
multiple studies.11 19–23 In a randomised controlled trial, 
Keranis et al reported that increasing the intake of antiox-
idants improved lung function.24
Cigarette smoking is the primary cause of COPD as 
it increases oxidative stress in the lungs and activates 
inflammatory responses.25 Notably, one inhalation from a 
cigarette generates more than 1015 free radicals and other 
oxidants.26
Antioxidants protect against the damage caused 
by smoking in multiple ways.3 For example, as it is 
Figure 3 Mean values of adjusted FEV1 measurements across quintiles of vitamin A, carotene and vitamin C intake 
(energy adjusted) in subjects with COPD. Adjusted for age, body mass index, energy intake, number of comorbid diseases, 
alcohol consumption, place of residence, household income and education level. P values were determined using tests for 
linear trends across increasing quintiles (means) of antioxidant vitamin intake. COPD, chronic obstructive pulmonary disease; 
FEV1, forced expiratory volume in 1 s.
Figure 4 Mean values of adjusted FEV1 measurements across quintiles of vitamin A, carotene and vitamin C intake 
(energy adjusted) in male patients with COPD according to smoking status. Values were adjusted for age, BMI, energy intake, 
number of comorbid diseases, alcohol consumption, place of residence, household income and education level. P values were 
determined using tests for linear trends across increasing quintiles (median) of antioxidant vitamin intake. BMI, body mass 
index; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s.
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water soluble, vitamin C scavenges free radicals in the 
cytoplasm. Koike et al reported that vitamin C diminished 
smoke-induced oxidative stress and corrected emphysem-
atous lungs in vivo.27
Carotenoids quench singlet oxygen and inhibit lipid 
peroxidation.3 In an animal study, the respiratory epithe-
lial of retinol-deficient animals had atrophied ciliated 
cells and modified lipid contents.28 The pathological 
features of the retinol-deficient animals were similar to 
those of human smokers.29
Smokers exhibit nicotine-induced reductions in intes-
tinal absorption and elevated metabolic turnover.30 
The metabolism or destruction of antioxidant vitamins 
increases in inflammatory environments,31–34 which 
suggests that smokers with COPD require larger amounts 
of antioxidant vitamins to achieve the same blood 
levels as non-smokers. A study by Sargeant and Jaeckel 
found that vitamin C may modify the adverse effects of 
smoking and the risk of COPD in the European popu-
lation.35 Additionally, Shin et al reported that Korean 
smokers with adequate vitamin C intake had acceptable 
pulmonary functions36 and Park et al showed that dietary 
vitamin C provides protection against COPD.37 Addition-
ally, Morabia et al identified that airway obstruction was 
reduced by vitamin A in smokers.11
One notable finding in the current study was that 
the effects of antioxidant vitamin intake on lung func-
tion were stronger among male smokers. Additionally, 
the association between the risk of COPD and antioxi-
dant vitamin intake was clear for male but not female 
smokers. Male smokers with lower antioxidant vitamin 
intakes had increased ORs of COPD compared with 
female smokers. Although the dose-dependent effect on 
COPD risk was not obvious in vitamin A and carotene, 
contrary to vitamin C (figure 2), male smokers with Q5 
intake showed a clearly reduced risk to develop COPD 
than male smokers with Q1 intake in all three antioxi-
dant vitamins.
After limiting the analysis to subjects with COPD, 
a significant association between antioxidant vitamin 
intake and FEV1 was observed in male smokers but not 
in other groups. This finding was similar to that of Joshi 
et al, where changes in COPD risk and dietary vitamin C 
and vitamin E intake differed between men and women.38
It is not known how gender differences impact pulmo-
nary functions based on antioxidant vitamin intake; 
however, animal studies have revealed gender differ-
ences in antioxidant vitamin requirements. Al-Rejaie et 
al reported gender-related differences in the protective 
roles of ascorbic acid against oxidative stress,39 whereas 
Jiao et al revealed gender differences in the regulation 
and expression of oxidative genes in mice.40
Studies detailing the effects of antioxidant vitamins on 
lung function in smokers and non-smokers are lacking.5 23 
In the US population, Britton et al revealed that the rela-
tionship between vitamin C intake and FEV1 was stronger 
in ex-smokers than non-smokers or current smokers.5 
Shahar et al reported a relationship between individuals 
in Q1 of vitamin A intake and airway obstruction among 
individuals who smoked >41 pack-years.23
Among male patients with COPD, those 
smoking ≥20 pack-years had improved lung functions 
as antioxidant vitamin intake increased. These results 
support that associations between antioxidants and 
lung function may differ according to smoking status 
in patients with COPD patients. However, it is unknown 
what causes such differences. One hypothesis is that the 
efficacy of antioxidant vitamins is proportional to the 
level of oxidant burden in COPD. Additional studies are 
required to determine whether the benefits of antioxi-
dant vitamins depend on the smoking duration or dose 
in patients with COPD.
This study has several limitations that should be noted. 
As we used a cross-sectional design, the data cannot be 
used to answer questions regarding causation. Addition-
ally, because data on nutritional intake were obtained 
by 24 hours recall, inaccurate responses may have been 
offered. This study used the prebronchodilator FEV1 for 
determining COPD; however, the definition of COPD is 
based on postbronchodilator FEV1.
15 This study failed to 
obtain data regarding air pollution or occupational expo-
sure and, therefore, could not associate these variables 
with lung function; however, the strength of this study is 
that these data represent the Korean population.
COnClusIOn
This study supports that antioxidant vitamins have benefi-
cial effects on pulmonary function in the Korean popula-
tion. The data indicate that there is a stronger association 
between antioxidant vitamin intake and the risk of COPD 
in male smokers. The beneficial effects of antioxidant 
vitamins in patients with COPD differed by gender and 
smoking status, and future investigations should deter-
mine the roles of dietary antioxidant vitamins in specific 
groups.
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